UBS Lux Equity Fund Biotech USD vs SEB Asienfond ex Japan D

UBS Lux Equity Fund Biotech USD vs SEB Asienfond ex Japan D

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. SEB Asienfond ex Japan D

  • Security

    SEB Asienfond ex Japan D USD Utd

  • Fee

    2.31%

  • ISIN

    SE0021150174

  • Holdings

    12

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with SEB Asienfond ex Japan D, we have 12 holdings where TSMC is the largest holding (9.48), followed by Meituan Class B (3.09) and MediaTek (2.95).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and SEB Asienfond ex Japan D.

UBS Lux Equity Fund Biotech USD SEB Asienfond ex Japan D
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Taiwan Semiconductor Manufacturing Company
Taiwan
9.48 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Meituan Class B
China
3.09 %
3. Moderna Inc
9.21 %
3. MediaTek Inc
Taiwan
2.95 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. SK Hynix Inc
South Korea
2.95 %
5. AbbVie Inc
USA
5.52 %
5. Samsung Electronics Co Ltd
South Korea
2.73 %
6. Gilead Sciences Inc
USA
4.66 %
6. Tencent
China
2.73 %
7. Amgen Inc
4.32 %
7. China Construction Bank Corp Class H
China
2.68 %
8. BioNTech SE
4.13 %
8. KB Financial Group Inc
South Korea
2.18 %
9. Karuna Therapeutics Inc
3.75 %
9. Bank of China Hong Kong Holdings Ltd
Hong Kong
2.14 %
10. Royalty Pharma Plc
3.28 %
10. Geely Automobile Holdings Ltd
China
2.12 %
- 11. Wistron Corp
Taiwan
2.06 %
- 12. Shanghai Pudong Development Bank Co Ltd
China
2 %

The list of fund holdings was last updated on April 17, 2025.